Safety assessment of nanomaterials: implications for nanomedicine.
Explore this paper's citation graph
Summary
Some of the major challenges related to safety of nanomedicines are discussed: are nanoparticles excreted, or biodegraded, or do they accumulate, potentially leading to harmful long-term effects?
- Type
- review
- Published
- 2012-07-20
- Cited by
- 250
- References
- 43
- OpenAlex
- https://openalex.org/W1969858206
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:19190219
Keywords
Nanomedicine, Nanotechnology, Drug delivery, Drug, Nanotoxicology
References
- Time evolution of the nanoparticle protein corona.
- Nanomedicine: reshaping clinical practice
- Toward the development of "nano-QSARs": advances and challenges.
- Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.
- The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century.
- Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots.
- Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
- Quantitative Nanostructure-Activity Relationship (QNAR) Modeling
- Use of a High Throughput Screening Approach Coupled With In Vivo Zebrafish Embryo Screening to Develop Hazard Ranking for Engineered Nanomaterials
- The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
- In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.
- Safe handling of nanotechnology
- Small-scale systems for in vivo drug delivery
- Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
- Nanotoxicology: no small matter.
- Biocompatibility and drug delivery systems
- Reconstituting Organ-Level Lung Functions on a Chip
- The evolution of the protein corona around nanoparticles: a test study.
Cited by
- Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.
- iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells.
- Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth
- Hyaluronic acid-coated gold nanoparticles as an anticancer drug delivery system - Biological characterization and efficacy
- Drug Delivery to the Respiratory Tract Using Dry Powder Inhalers
- Chemistry of multifunctional polymers based on bis-MPA and their cutting-edge applications
- Risks to Health Care Workers from Nano-Enabled Medical Products
- Nanoinformatics: a new area of research in nanomedicine
- The bio-corona and its impact on nanomaterial toxicity
- Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: challenges, considerations and strategy
- Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
- Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials
- Applications of nanoparticles for diagnosis and therapy of cancer
- Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.
- The nanoparticle biomolecule corona: lessons learned - challenge accepted?
- Nanotherapeutics in the EU: an overview on current state and future directions
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology.
- Targeted Nanoparticles for Cardiovascular Molecular Imaging
- Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel.
- Swedish Medical Nanoscience Center at Karolinska Institutet